{
  "openalex_id": "W1500256912",
  "doi": "https://doi.org/10.1158/1538-7445.sabcs14-pd3-5",
  "title": "Abstract PD3-5: Whole exome sequencing (WES) of HER2+ metastatic breast cancer (MBC) from patients with or without prior trastuzumab (T): A correlative analysis of TBCRC003",
  "abstract": "Abstract Background: Although the spectrum of genomic alterations in primary, treatment-naïve breast tumors has been described, the genomic landscape of HER2+ MBC remains underexplored. Furthermore, tumor genomic alterations that arise after progression on anti-HER2 therapy are largely unknown. Methods: We prospectively collected metastatic tumor biopsies from patients (pts) enrolled on TBCRC003 (NCT00470704), a phase II study evaluating the combination of lapatinib (L) and T in pts with HER2+ MBC who had varying degrees of prior T exposure. We performed WES on baseline metastatic biopsies and normal DNA from 57 pts. In 36 pts, we also performed WES on pre-treatment primary tumors. Tumors were analyzed for point mutations, insertions/deletions, and copy number alterations. Results: Total accrual was 116 pts. 87 pts were registered in one of two efficacy cohorts: Cohort 1 included pts w no prior T for MBC. Pts with prior adjuvant T were included if the interval from last T to 1st recurrence &amp;gt; 12 months. Cohort 2 included pts with 1-2 prior lines of T for MBC or recurrence within 12 months of adjuvant T. An additional 29 pts were enrolled in a biomarker cohort (Cohort 3). Per-protocol efficacy analyses for 85 pts deemed evaluable are shown below: Objective Response RateClinical Benefit RateMedian Time to ProgressionCohort 150% (90% CI 33.8-66.2%)57.5% (95% CI 40.9-73.0)7.4 monthsCohort 222.2% (90% CI 11.2-37.1%)42.2% (95% CI 27.7-57.8)5.3 months As we previously reported (Wagle et al, ASCO 2014), across 57 metastatic tumors, significant recurrently mutated genes were TP53 (n=30; 53%) and PIK3CA (n=19; 33%). The frequency of mutant TP53 and PIK3CA was not significantly different from 119 primary, treatment-naïve HER2+ tumors sequenced in the TCGA study (50%, p=0.8 and 27%, p=0.5, respectively). Recurrent copy number alterations were also similar to TCGA data. Comparing the 38 pts who received any prior T with the 19 pts who did not, there was no significant difference in the incidence of mutant TP53 (53% vs 53%, p=1.0) and PIK3CA (37% vs 26%, p=0.6). We identified mutations in the HER2 kinase domain in 4/38 pts who received prior T (11%), as compared to 0/19 T-naïve pts. HER2 kinase domain mutations have been identified in ∼2% of HER2-negative cancers but &amp;lt;1% of primary HER2+ cancers. 3 of the mutations were L755S, which has been shown to be resistant to L and sensitive to irreversible HER2 inhibitors. The 4th mutation was D742N, a novel kinase domain mutation. None of the 4 pts with HER2 kinase domain mutations had an objective response, though 1 pt had stable disease for 29 weeks. An analysis comparing paired archival primary tumors and baseline metastatic biopsies from 36 pts to identify genomic alterations acquired or enriched in the metastatic tumors will be presented. Conclusions: We present an analysis of the genomic landscape of HER2+ MBC, including comparisons between matched primary tumors and metastatic biopsies. Somatic HER2 kinase mutations in pts with HER2+ MBC treated with prior T suggests that these mutations may be involved in resistance to T, and may predict poor response to additional anti-HER2 therapy with combined L and T. Novel therapeutic approaches may be required for these pts. Citation Format: Nikhil Wagle, Nancy U Lin, Andrea L Richardson, Ignaty Leshchiner, Ingrid A Mayer, Andres Forero-Torres, Timothy J Hobday, Elizabeth C Dees, Rita Nanda, Mothaffar F Rimawi, Hao Guo, William T Barry, Ron Bose, Wei Shen, Antonio C Wolff, Stacey B Gabriel, Levi A Garraway, Eric P Winer, Ian E Krop. Whole exome sequencing (WES) of HER2+ metastatic breast cancer (MBC) from patients with or without prior trastuzumab (T): A correlative analysis of TBCRC003 [abstract]. In: Proceedings of the Thirty-Seventh Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2014 Dec 9-13; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2015;75(9 Suppl):Abstract nr PD3-5.",
  "authors": [
    {
      "display_name": "Nikhil Wagle",
      "id": "A5068721624",
      "orcid": "https://orcid.org/0000-0003-3332-9438",
      "institutions": [
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Nikhil Wagle"
    },
    {
      "display_name": "Nancy U. Lin",
      "id": "A5049174232",
      "orcid": "https://orcid.org/0000-0003-2263-5413",
      "institutions": [
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Nancy U Lin"
    },
    {
      "display_name": "Andrea L. Richardson",
      "id": "A5015821699",
      "orcid": "https://orcid.org/0000-0001-5221-1094",
      "institutions": [
        {
          "id": "I4210097513",
          "display_name": "Women's Hospital",
          "country_code": "US",
          "type": "healthcare"
        },
        {
          "id": "I1283280774",
          "display_name": "Brigham and Women's Hospital",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Andrea L Richardson"
    },
    {
      "display_name": "Ignaty Leshchiner",
      "id": "A5061172218",
      "orcid": "https://orcid.org/0000-0001-8942-9265",
      "institutions": [
        {
          "id": "I107606265",
          "display_name": "Broad Institute",
          "country_code": "US",
          "type": "nonprofit"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Ignaty Leshchiner"
    },
    {
      "display_name": "Ingrid A. Mayer",
      "id": "A5069182089",
      "orcid": "https://orcid.org/0000-0001-8147-335X",
      "institutions": [
        {
          "id": "I196764719",
          "display_name": "Breast Cancer Research Foundation",
          "country_code": "US",
          "type": "nonprofit"
        },
        {
          "id": "I4390039299",
          "display_name": "Vanderbilt-Ingram Cancer Center",
          "country_code": null,
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Ingrid A Mayer"
    },
    {
      "display_name": "Andres Forero‐Torres",
      "id": "A5012750761",
      "orcid": "https://orcid.org/0000-0001-5161-8319",
      "institutions": [
        {
          "id": "I17301866",
          "display_name": "University of Alabama",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Andres Forero-Torres"
    },
    {
      "display_name": "Timothy J. Hobday",
      "id": "A5078619764",
      "orcid": "https://orcid.org/0000-0002-9877-3372",
      "institutions": [
        {
          "id": "I2802423016",
          "display_name": "WinnMed",
          "country_code": "US",
          "type": "nonprofit"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Timothy J Hobday"
    },
    {
      "display_name": "Elizabeth Claire Dees",
      "id": "A5016973435",
      "orcid": "https://orcid.org/0000-0003-4004-7316",
      "institutions": [
        {
          "id": "I4210150070",
          "display_name": "Segeberger Kliniken",
          "country_code": "DE",
          "type": "healthcare"
        },
        {
          "id": "I4390039329",
          "display_name": "UNC Lineberger Comprehensive Cancer Center",
          "country_code": null,
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Elizabeth C Dees"
    },
    {
      "display_name": "Rita Nanda",
      "id": "A5005007467",
      "orcid": "https://orcid.org/0000-0001-5248-0876",
      "institutions": [
        {
          "id": "I40347166",
          "display_name": "University of Chicago",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Rita Nanda"
    },
    {
      "display_name": "Mothaffar F. Rimawi",
      "id": "A5072850149",
      "orcid": "https://orcid.org/0000-0002-4284-5656",
      "institutions": [
        {
          "id": "I181547552",
          "display_name": "Baylor College of Medicine",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Mothaffar F Rimawi"
    },
    {
      "display_name": "Hao Guo",
      "id": "A5071781807",
      "orcid": "https://orcid.org/0000-0003-1658-0989",
      "institutions": [
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Hao Guo"
    },
    {
      "display_name": "William T. Barry",
      "id": "A5112035683",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "William T Barry"
    },
    {
      "display_name": "Ron Bose",
      "id": "A5001373717",
      "orcid": "https://orcid.org/0000-0003-1977-8894",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Ron Bose"
    },
    {
      "display_name": "Wei Shen",
      "id": "A5048353325",
      "orcid": "https://orcid.org/0000-0002-1235-598X",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Wei Shen"
    },
    {
      "display_name": "Antonio C. Wolff",
      "id": "A5026024346",
      "orcid": "https://orcid.org/0000-0003-3734-1063",
      "institutions": [
        {
          "id": "I4210150714",
          "display_name": "Johns Hopkins Hospital",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Antonio C Wolff"
    },
    {
      "display_name": "Stacey Gabriel",
      "id": "A5108378152",
      "orcid": null,
      "institutions": [
        {
          "id": "I107606265",
          "display_name": "Broad Institute",
          "country_code": "US",
          "type": "nonprofit"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Stacey B Gabriel"
    },
    {
      "display_name": "Levi A. Garraway",
      "id": "A5055048393",
      "orcid": "https://orcid.org/0000-0003-3739-0471",
      "institutions": [
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Levi A Garraway"
    },
    {
      "display_name": "Eric P. Winer",
      "id": "A5070245248",
      "orcid": "https://orcid.org/0000-0002-8819-1723",
      "institutions": [
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Eric P Winer"
    },
    {
      "display_name": "Ian E. Krop",
      "id": "A5032785430",
      "orcid": "https://orcid.org/0000-0002-6380-5944",
      "institutions": [
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Ian E Krop"
    }
  ],
  "publication_year": 2015,
  "publication_date": "2015-05-01",
  "type": "article",
  "cited_by_count": 6,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S168522863",
    "display_name": "Cancer Research",
    "issn_l": "0008-5472",
    "issn": [
      "0008-5472",
      "1538-7445"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310320273"
  },
  "volume": "75",
  "issue": "9_Supplement",
  "first_page": "PD3",
  "last_page": "5",
  "open_access": {
    "is_oa": false,
    "oa_status": "closed",
    "oa_url": null,
    "any_repository_has_fulltext": false
  },
  "concepts": [
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.8831994
    },
    {
      "id": "C2775930923",
      "display_name": "Metastatic breast cancer",
      "level": 4,
      "score": 0.80037737
    },
    {
      "id": "C2779786085",
      "display_name": "Trastuzumab",
      "level": 4,
      "score": 0.77482045
    },
    {
      "id": "C2777329042",
      "display_name": "Lapatinib",
      "level": 5,
      "score": 0.71606624
    },
    {
      "id": "C72563966",
      "display_name": "Cohort",
      "level": 2,
      "score": 0.69753563
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.65647054
    },
    {
      "id": "C530470458",
      "display_name": "Breast cancer",
      "level": 3,
      "score": 0.5888178
    },
    {
      "id": "C143998085",
      "display_name": "Oncology",
      "level": 1,
      "score": 0.5355354
    },
    {
      "id": "C203092338",
      "display_name": "Clinical endpoint",
      "level": 3,
      "score": 0.53436786
    },
    {
      "id": "C121608353",
      "display_name": "Cancer",
      "level": 2,
      "score": 0.42713207
    },
    {
      "id": "C90924648",
      "display_name": "Gastroenterology",
      "level": 1,
      "score": 0.40041983
    },
    {
      "id": "C535046627",
      "display_name": "Clinical trial",
      "level": 2,
      "score": 0.17415252
    }
  ],
  "topics": [
    {
      "id": "T11287",
      "display_name": "Cancer Genomics and Diagnostics",
      "score": 0.9976
    },
    {
      "id": "T12829",
      "display_name": "Advanced Breast Cancer Therapies",
      "score": 0.9866
    },
    {
      "id": "T10417",
      "display_name": "Lung Cancer Treatments and Mutations",
      "score": 0.9845
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.1158/1538-7445.sabcs14-pd3-5",
  "pdf_url": null,
  "retrieved_date": "2025-07-30T15:36:41.242493",
  "source_database": "OpenAlex"
}